Brian Millham - 22 Sep 2024 Form 4 Insider Report for Salesforce, Inc. (CRM)

Role
President and COO
Signature
/s/ Sarah Dale, Attorney-in-Fact for Brian Millham
Issuer symbol
CRM
Transactions as of
22 Sep 2024
Net transactions value
-$712,456
Form type
4
Filing time
23 Sep 2024, 20:59:15 UTC
Previous filing
23 Aug 2024
Next filing
25 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRM Common Stock Options Exercise $0 +1,635 $0.000000 1,635 22 Sep 2024 Direct
transaction CRM Common Stock Options Exercise $0 +1,707 +104% $0.000000 3,342 22 Sep 2024 Direct
transaction CRM Common Stock Sale $217,385 -821 -25% $264.78 2,521 23 Sep 2024 Direct F1
transaction CRM Common Stock Sale $227,182 -858 -34% $264.78 1,663 23 Sep 2024 Direct F1
transaction CRM Common Stock Options Exercise $380,107 +2,038 +123% $186.51 3,701 23 Sep 2024 Direct F2
transaction CRM Common Stock Options Exercise $434,213 +2,018 +55% $215.17 5,719 23 Sep 2024 Direct F2
transaction CRM Common Stock Sale $229,006 -863 -15% $265.36 4,856 23 Sep 2024 Direct F2, F3
transaction CRM Common Stock Sale $800,456 -2,996 -62% $267.17 1,860 23 Sep 2024 Direct F2, F4
transaction CRM Common Stock Sale $52,747 -197 -11% $267.75 1,663 23 Sep 2024 Direct F2, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRM Restricted Stock Units Options Exercise $0 -1,635 -33% $0.000000 3,269 22 Sep 2024 Common Stock 1,635 $0.000000 Direct F6, F7
transaction CRM Restricted Stock Units Options Exercise $0 -1,707 -14% $0.000000 10,239 22 Sep 2024 Common Stock 1,707 $0.000000 Direct F6, F8
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -2,038 -3.2% $0.000000 61,132 23 Sep 2024 Common Stock 2,038 $186.51 Direct F2, F9
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -2,018 -14% $0.000000 12,107 23 Sep 2024 Common Stock 2,018 $215.17 Direct F2, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents a sale of shares to satisfy the tax withholding obligations of the Issuer with respect to the settlement of shares that were earned by the holder pursuant to a restricted stock unit award that vested based on the holder's continued employment through September 22, 2024.
F2 As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2023.
F3 Weighted average price. These shares were sold in multiple transactions at prices ranging from $264.9900 to $265.7200 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4 Weighted average price. These shares were sold in multiple transactions at prices ranging from $266.3700 to $267.2500 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5 Weighted average price. These shares were sold in multiple transactions at prices ranging from $267.7300 to $267.7700 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F6 Restricted Stock Units convert to shares of common stock on a one-for-one basis.
F7 These restricted stock units vest as to 25% of the original grant on March 22, 2022, and vest as to 1/16 of the original grant quarterly thereafter.
F8 These restricted stock units vest as to 25% of the original grant on March 22, 2023, and vest as to 1/16 of the original grant quarterly thereafter.
F9 Option is exercisable and vests over four years at the rate of 25% on March 22, 2024, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F10 Option is exercisable and vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.